{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:43:47Z","timestamp":1786718627355,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/1673-5374.232530","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T01:07:49Z","timestamp":1526432869000},"page":"1657","source":"Crossref","is-referenced-by-count":27,"title":["Treatment with NADPH oxidase inhibitor apocynin alleviates diabetic neuropathic pain in rats"],"prefix":"10.4103","volume":"13","author":[{"given":"Sibel","family":"\ufffdlker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Olukman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayt\u00fcl","family":"\u00d6nal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FatmaG\u00fcl","family":"\u00c7elenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi\u011fit","family":"Uyan\u0131kgil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00fcrker","family":"\u00c7avu\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neslihan","family":"D\u00fczenli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.232530-1","doi-asserted-by":"crossref","unstructured":"\u2018t Hart BA, Simons JM, Knaan-Shanzer S, Bakker NP, Labadie RP (1990) Antiarthritic activity of the newly developed neutrophil oxidative burst antagonist apocynin. Free Radic Biol Med 9:127-131.","DOI":"10.1016\/0891-5849(90)90115-Y"},{"key":"key-10.4103\/1673-5374.232530-2","doi-asserted-by":"crossref","unstructured":"Al-Shabrawey M, Rojas M, Sanders T, Behzadian A, El-Remessy A, Bartoli M, Parpia AK, Liou G, Caldwell RB (2008) Role of NADPH oxidase in retinal vascular inflammation. Invest Ophthalmol Vis Sci 49:3239-3244.","DOI":"10.1167\/iovs.08-1755"},{"key":"key-10.4103\/1673-5374.232530-3","doi-asserted-by":"crossref","unstructured":"Aldieri E, Riganti C, Polimeni M, Gazzano E, Lussiana C, Campia I, Ghigo D (2008) Classical inhibitors of NOX NAD(P)H oxidases are not specific. Curr Drug Metab 9:686-696.","DOI":"10.2174\/138920008786049285"},{"key":"key-10.4103\/1673-5374.232530-4","doi-asserted-by":"crossref","unstructured":"Aldskogius H, Kozlova EN (1998) Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol 55:1-26.","DOI":"10.1016\/S0301-0082(97)00093-2"},{"key":"key-10.4103\/1673-5374.232530-5","doi-asserted-by":"crossref","unstructured":"Babizhayev MA, Strokov IA, Nosikov VV, Savel\u2019yeva EL, Sitnikov VF, Yegorov YE, Lankin VZ (2015) The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type I diabetic patients. Cell Biochem Biophys 71:1425-1443.","DOI":"10.1007\/s12013-014-0365-y"},{"key":"key-10.4103\/1673-5374.232530-6","doi-asserted-by":"crossref","unstructured":"Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988.","DOI":"10.1007\/s001250100001"},{"key":"key-10.4103\/1673-5374.232530-7","doi-asserted-by":"crossref","unstructured":"Cotter MA, Cameron NE (2003) Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci 73:1813-1824.","DOI":"10.1016\/S0024-3205(03)00508-3"},{"key":"key-10.4103\/1673-5374.232530-8","doi-asserted-by":"crossref","unstructured":"de M Bandeira S, da Fonseca LJ, da S Guedes G, Rabelo LA, Goulart MO, Vasconcelos SM (2013) Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci 14:3265-3284.","DOI":"10.3390\/ijms14023265"},{"key":"key-10.4103\/1673-5374.232530-9","doi-asserted-by":"crossref","unstructured":"Drummond GR, Selemidis S, Griendling KK, Sobey CG (2011) Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat Rev Drug Discov 10:453-471.","DOI":"10.1038\/nrd3403"},{"key":"key-10.4103\/1673-5374.232530-10","doi-asserted-by":"crossref","unstructured":"Guedes RP, Ara\u00fajo AS, Janner D, Bell\u00f3-Klein A, Ribeiro MF, Partata WA (2008) Increase in reactive oxygen species and activation of Akt signaling pathway in neuropathic pain. Cell Mol Neurobiol 28:1049-1056.","DOI":"10.1007\/s10571-008-9279-9"},{"key":"key-10.4103\/1673-5374.232530-11","doi-asserted-by":"crossref","unstructured":"Kallenborn-Gerhardt W, Schr\u00f6der K, Geisslinger G, Schmidtko A (2013) NOXious signaling in pain processing. Pharmacol Ther 137:309-317.","DOI":"10.1016\/j.pharmthera.2012.11.001"},{"key":"key-10.4103\/1673-5374.232530-12","doi-asserted-by":"crossref","unstructured":"Kishi Y, Nickander KK, Schmelzer JD, Low PA (2000) Gene expression of antioxidant enzymes in experimental diabetic neuropathy. J Peripher Nerv Syst 5:11-18.","DOI":"10.1046\/j.1529-8027.2000.00144.x"},{"key":"key-10.4103\/1673-5374.232530-13","doi-asserted-by":"crossref","unstructured":"Majithiya JB, Balaraman R (2005) Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 46:697-705.","DOI":"10.1097\/01.fjc.0000183720.85014.24"},{"key":"key-10.4103\/1673-5374.232530-14","doi-asserted-by":"crossref","unstructured":"Morrow TJ (2004) Animal models of painful diabetic neuropathy: the STZ rat model. Curr Protoc Neurosci Chapter 9:Unit 9.18.","DOI":"10.1002\/0471142301.ns0918s29"},{"key":"key-10.4103\/1673-5374.232530-15","doi-asserted-by":"crossref","unstructured":"Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH (2009) Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Res Clin Pract 83:176-182.","DOI":"10.1016\/j.diabres.2008.10.007"},{"key":"key-10.4103\/1673-5374.232530-16","doi-asserted-by":"crossref","unstructured":"Obrosova IG (2009) Diabetes and the peripheral nerve. Biochim Biophys Acta 1792:931-940.","DOI":"10.1016\/j.bbadis.2008.11.005"},{"key":"key-10.4103\/1673-5374.232530-17","doi-asserted-by":"crossref","unstructured":"Olukman M, Orhan CE, Celenk FG, Ulker S (2010) Apocynin restores endothelial dysfunction in streptozotocin diabetic rats through regulation of nitric oxide synthase and NADPH oxidase expressions. J Diabetes Complications 24:415-423.","DOI":"10.1016\/j.jdiacomp.2010.02.001"},{"key":"key-10.4103\/1673-5374.232530-18","doi-asserted-by":"crossref","unstructured":"Patel M, Li QY, Chang LY, Crapo J, Liang LP (2005) Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage. J Neurochem 92:123-131.","DOI":"10.1111\/j.1471-4159.2004.02838.x"},{"key":"key-10.4103\/1673-5374.232530-19","doi-asserted-by":"crossref","unstructured":"Rom\u00e1n-Pintos LM, Villegas-Rivera G, Rodr\u00edguez-Carrizalez AD, Miranda-D\u00edaz AG, Cardona-Mu\u00f1oz EG (2016) Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. J Diabetes Res 2016:3425617.","DOI":"10.1155\/2016\/3425617"},{"key":"key-10.4103\/1673-5374.232530-20","doi-asserted-by":"crossref","unstructured":"Russell JW, Zilliox LA (2014) Diabetic neuropathies. Continuum (Minneap Minn) 20:1226-1240.","DOI":"10.1212\/01.CON.0000455884.29545.d2"},{"key":"key-10.4103\/1673-5374.232530-21","doi-asserted-by":"crossref","unstructured":"Sandk\u00fchler J (2009) Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 89:707-758.","DOI":"10.1152\/physrev.00025.2008"},{"key":"key-10.4103\/1673-5374.232530-22","doi-asserted-by":"crossref","unstructured":"Santos-Nogueira E, Redondo Castro E, Mancuso R, Navarro X (2012) Randall-Selitto test: a new approach for the detection of neuropathic pain after spinal cord injury. J Neurotrauma 29:898-904.","DOI":"10.1089\/neu.2010.1700"},{"key":"key-10.4103\/1673-5374.232530-23","doi-asserted-by":"crossref","unstructured":"Zenker J, Ziegler D, Chrast R (2013) Novel pathogenic pathways in diabetic neuropathy. Trends Neurosci 36:439-449.","DOI":"10.1016\/j.tins.2013.04.008"},{"key":"key-10.4103\/1673-5374.232530-24","doi-asserted-by":"crossref","unstructured":"Zhao WC, Zhang B, Liao MJ, Zhang WX, He WY, Wang HB, Yang CX (2014) Curcumin ameliorated diabetic neuropathy partially by inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Neurosci Lett 560:81-85.","DOI":"10.1016\/j.neulet.2013.12.019"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:38Z","timestamp":1786714658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.232530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018]]}},"alternative-id":["232530"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.232530","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}